• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEL AM filed by AIxCrypto Holdings Inc.

    12/8/25 1:50:02 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIXC alert in real time by email
    DEL AM 1 formdelam.htm DEL AM

     

     

    December 8, 2025

     

    Via EDGAR

     

    Securities and Exchange Commission

    100 F Street, NE

    Washington, D.C. 20549

     

      Re: AIxCrypto Holdings, Inc.
        Registration Statement on Form S-1
        (File No. 333-291926) filed on December 4, 2025

     

    To Whom It May Concern:

     

    Reference is made to the Registration Statement on Form S-1 (File No. 333-291926) filed by AIxCrypto Holdings, Inc. (the “Issuer”) on December 4, 2025 (the “Registration Statement”).

     

    Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the “Act”), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated onto the facing page of the Registration Statement immediately following the calculation of registration fee table:

     

    “The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the SEC, acting pursuant to said Section 8(a) may determine.”

     

    Should you have any questions regarding the Registration Statement, please feel free to contact Peter Campitiello, counsel to the Issuer at (732) 395-4517.

     

    Very truly yours,

     

    /s/ Kevin A. Richardson II

     

    Co-Chief Executive Officer

    AIxCrpto Holdings, Inc.

     

    cc: Peter Campitiello, Esq.

     

     

     

     

    Get the next $AIXC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIXC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AIXC
    SEC Filings

    View All

    AIxCrypto Holdings Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    12/15/25 8:03:33 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by AIxCrypto Holdings Inc.

    DEF 14A - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    12/15/25 10:11:02 AM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by AIxCrypto Holdings Inc.

    EFFECT - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    12/12/25 12:15:14 AM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIXC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Wang Jiawei claimed ownership of 1,658 shares (SEC Form 3)

    3 - AIxCrypto Holdings, Inc. (0001460702) (Issuer)

    12/5/25 7:46:10 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIXC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    YT Jia, Chief Advisor to AIxC Shares Weekly AIxC Investor Update: AIxC Appointed Andrew Grossman as Head of Legal Where he will Take Full Responsibility for the Company's Legal, Compliance, and Governance Framework

    Weekly report is now upgraded to the dual public Company structure weekly update and will report the progress of the Company's dual flywheel businesses every week.LOS ANGELES, Dec. 14, 2025 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or ", the Company", )) today shared a weekly business update from YT Jia, Chief Advisor of AIxC and Founder and Global Co-CEO of Faraday Future (NASDAQ:FFAI). "As I serve as Chief Advisor to AIxC, with the Company's day-to-day operations led by its executive management team, I will continue to report the progress of the Company's Dual F

    12/14/25 11:44:00 PM ET
    $AIXC
    $FFAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials

    AIxCrypto Rebrands and Begins Trading Under New Ticker AIXC, Advancing Its "Three Driving Forces" Strategy to Become the No.1 Gateway to AI Web3 and a Bridge Between Web2 and Web3

    The FFAI + AIXC "dual flywheel, dual bridge, dual listing" framework has now been fully established, ushering in a new era of high-speed, two-way empowerment between EAI and Crypto. This approach delivers transformative Web3 value to Web2 while also bringing substantial off-chain Web2 growth into Web3. Breaking boundaries and fostering integration—rather than operating in isolation—is the true future of the Web3 industry.AIxCrypto (AIXC) is now focused on its new "Three Driving Forces" strategy, aimed at becoming the No.1 gateway into the AI Web3 world:BesTrade DeAI Agent & Web3 AI Terminal – the No.1 entry point for Web3 trading, integrating intelligent AI agents with user-facing trading in

    11/20/25 12:36:00 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care